97
Views
13
CrossRef citations to date
0
Altmetric
Original Research

High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

, , , , , , & show all
Pages 343-352 | Published online: 16 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hung-Chin Tsai, I-Tzu Chen, Hui-Min Chang, Susan Shin-Jung Lee & Yao-Shen Chen. (2022) High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen. Infection and Drug Resistance 15, pages 3857-3869.
Read now
Hung-Chin Tsai, I-Tzu Chen, Susan Shin-Jung Lee & Yao-Shen Chen. (2018) HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan. Infection and Drug Resistance 11, pages 1061-1071.
Read now

Articles from other publishers (11)

Hui-Min Chang, Chen-Hsi Chou & Hung-Chin Tsai. (2022) Durability of single tablet regimen for patients with HIV infection in Southern Taiwan: data from a real-world setting. BMC Infectious Diseases 22:1.
Crossref
Rachel SnoMergiory Y. Labadie-BrachoMeritha G. GrünbergMalti R. Adhin. (2021) First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname. AIDS Research and Human Retroviruses 37:7, pages 557-565.
Crossref
Dong Joo Seo & Changsun Choi. (2021) Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review. Viruses 13:2, pages 350.
Crossref
Yun Lan, Ruolei Xin, Weiping Cai, Xizi Deng, Linghua Li, Feng Li, Xiaoli Cai, Xiaoping Tang, Qinghong Fan & Fengyu Hu. (2020) Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China. Journal of Antimicrobial Chemotherapy 75:7, pages 1925-1931.
Crossref
Farah Bokharaei-Salim, Maryam Esghaei, Khadijeh Khanaliha, Saeed Kalantari, Arezoo Marjani, Atousa Fakhim & Hossein Keyvani. (2020) HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals. PLOS ONE 15:3, pages e0229275.
Crossref
Umesh Panwar, Ishwar Chandra, Chandrabose Selvaraj & Sanjeev K. Singh. (2019) Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview. Current Pharmaceutical Design 25:31, pages 3390-3405.
Crossref
Amir Shroufi, Gilles Van Cutsem, Valentina Cambiano, Loveleen Bansi-Matharu, Kristal Duncan, Richard A. Murphy, David Maman & Andrew Phillips. (2019) Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa. AIDS 33:10, pages 1635-1644.
Crossref
Viviane Machado Andrade & Mario Stevenson. (2018) Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1. Journal of Neuroimmune Pharmacology 14:1, pages 33-43.
Crossref
George Awungafac, Elvis T. Amin, Akemfua Fualefac, Noah F. Takah, Lucy A. Agyingi, Julius Nwobegahay, Pascale Ondoa & Patrick A. Njukeng. (2018) Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface. PLOS ONE 13:6, pages e0198686.
Crossref
Sang-Ah Lee, Shin-Woo Kim, Hyun-Ha Chang, Hyejin Jung, Yoonjung Kim, Soyoon Hwang, Sujeong Kim, Han-Ki Park & Jong-Myung Lee. (2018) Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus. Infection & Chemotherapy 50:3, pages 252.
Crossref
Titus Tambaip, Marni Br Karo, Mochammad Hatta, Ressy Dwiyanti, Rosdiana Natzir, Muh Nasrum Mas, Andi Asadul Isl & Khairuddin Djawad. (2018) Immunomodulatory Effect of Orally Red Fruit (Pandanus conoideus) Extract on the Expression of CC Chemokine Receptor 5 mRNA in HIV Patients with Antiretroviral Therapy. Research Journal of Immunology 11:1, pages 15-21.
Crossref